Company / Inventory
TEVA PHARMACEUTICAL INDUSTRIES LTD Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$3.2B
FY2025
5-year range
$3.0B / $4.0B
FY2021-FY2025
Trend
+5.7%
vs FY2024
Sector context
#9 of 105
Health Care
What the data says
Among 105 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 9% for inventory. Inventory has fluctuated over the past 10 years, ranging from $3.0B in FY2024 to $5.0B in FY2016.
Based on SEC 10-K filings.
$3.2B in FY2025 with a 5-year CAGR of -6.3%. Top quartile in the Health Care sector.
Declined from $4.0B to $3.2B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -6.3%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 105This company $3.2B Sector average $885.3M
▼
+259.1% above sector average
Key checks
Key Insights
- 5-year CAGR of -6.3%, indicating a declining trend.
- In FY2025, inventory increased 5.7% year-over-year.
- Ranks #9 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.2B | +5.7% |
| FY2024 | $3.0B | -25.2% |
| FY2023 | $4.0B | +4.9% |
| FY2022 | $3.8B | +0.4% |
| FY2021 | $3.8B | -13.3% |
| FY2020 | $4.4B | -0.4% |
| FY2019 | $4.4B | -6.5% |
| FY2018 | $4.7B | -3.9% |
| FY2017 | $4.9B | -0.6% |
| FY2016 | $5.0B | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026